Life sciences and healthcare companies with a current or potential R&D interest in London - please take part in a five minute online study
Commercial property advisory company Creative Places is leading a study to explore how London in the context of the broader ‘golden triangle’ should develop to promote better collaboration, productivity and growth for companies involved in life sciences R&D.
The company is working with MedCity, university and NHS partners, the London Enterprise Panel and the GLA to analyse how London can deliver what industry, research centres and health services need in order to underpin the innovation pipeline – from research to the adoption of new products and services.
Life sciences and healthcare companies with a current or potential R&D interest in London are asked to provide input by participating in this five minute online study.
MedCity CEO Sarah Haywood says: “The greater south east is one of the world’s prime life sciences clusters and one of the repeated challenges that companies ask MedCity to support them with is finding the right sort of space in the areas they want to be. Our growth and competitiveness depends on being able to meet this demand, which we need to understand in-depth in order to plan long-term for the right development and infrastructure in the right locations.”
Jonathan Burroughs of Creative Places, who is leading the demand study, adds: “We have been taking a close look at international comparators like New York and Boston to ensure we truly strive to deliver excellence. The UK needs to build for the future, so we want to hear from as many businesses as possible who have an interest in or experience of working and growing in the region.”